-
Article
-
Detection of colistin-resistant populations prior to antibiotic exposure in KPC-2-producing Klebsiella pneumoniae clinical isolates
-
Jungyu Seo 1, Yu Mi Wi 2, Jong Min Kim 3, Yae-Jean Kim 4, Kwan Soo Ko 1
-
Journal of Microbiology 2021;59(6):590-597.
DOI: https://doi.org/10.1007/s12275-021-0610-1
Published online: March 29, 2021
1Department of Microbiology and Samsung Medical Center, Sungkyunkwan University School of Medicine, Suwon 16419, Republic of Korea, 2Division of Infectious Diseases, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon 51353, Republic of Korea, 3Department of Pediatrics, Myongji Hospital, Goyang 10475, Republic of Korea, 4Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06355, Republic of Korea
Received: 23 November 2020 • Revised: 26 January 2021 • Accepted: 9 February 2021
-
612
Views
-
4
Download
-
11
Web of Science
-
10
Crossref
-
11
Scopus
Abstract
Although colistin is frequently regarded as the antibiotic of
last resort in treating carbapenem-resistant Klebsiella pneumoniae,
colistin heteroresistance may in part be associated
with antibiotic treatment failure. However, we do not know
how widespread the colistin heteroresistance is in carbapenem-
resistant K. pneumoniae isolates. In this study, we performed
colistin disc diffusion assays, E-tests, and population
analysis profiling for KPC-2-producing K. pneumoniae isolates
to identify colistin heteroresistance. Although no colistin-
resistant colonies were detected by the disc diffusion
test and E-test, a colistin-resistant subpopulation was identified
in population analysis profiling in all colistin-susceptible,
KPC-2-producing K. pneumoniae isolates. Colistin-resistant
subpopulations were also identified even when isolates
had no colistin exposure. The ratio of colistin-resistant
subpopulations to the total population increased as the exposure
concentration of colistin increased. In in vitro time-kill
assays, regrowth was observed in all isolates after 2 h upon
exposure to colistin. We identified common amino acid alterations
in PhoQ, PhoP, and PmrB in colistin-resistant subpopulations
from some isolates, but no substitutions were
found in most resistant subpopulations from other isolates.
In all colistin-resistant subpopulations, overexpression of
PhoQ and PbgP was observed. In this study, we demonstrated
that colistin heteroresistance may be common in KPC-2-producing
K. pneumoniae isolates, which could not be detected
in the disc diffusion method and E-test. Colistin heteroresistance
may cause colistin treatment failure in part and may
evolve into resistance. Thus, development of more reliable
diagnostic methods is required to detect colistin heteroresistance.
Supplementary Information
Citations
Citations to this article as recorded by

- High prevalence of polymyxin-heteroresistant carbapenem-resistant Klebsiella pneumoniae and its within-host evolution to resistance among critically ill scenarios
Xiaoli Wang, Tianjiao Meng, Yunqi Dai, Hong-Yu Ou, Meng Wang, Bin Tang, Jingyong Sun, Decui Cheng, Tingting Pan, Ruoming Tan, Hongping Qu
Infection.2025; 53(1): 271. CrossRef - Detection and characterization of heteroresistance to chloramphenicol in Klebsiella pneumoniae isolates
Qihong Kuang, Xiaorui Zhang, Fangping Ou, Lingling Liu, Hui Deng, Bo Yang, Lingxian Yi, Daojin Yu
BMC Microbiology.2025;[Epub] CrossRef - Development of colistin resistance via heteroresistance modeling in Klebsiella pneumoniae: A diagnostic study
Jungyu Seo, Kwan Soo Ko
Precision and Future Medicine.2024; 8(1): 10. CrossRef - Conversion to colistin susceptibility by tigecycline exposure in colistin-resistant Klebsiella pneumoniae and its implications to combination therapy
Suyeon Park, Jihyun Choi, Dongwoo Shin, Ki Tae Kwon, Si-Ho Kim, Yu Mi Wi, Kwan Soo Ko
International Journal of Antimicrobial Agents.2024; 63(1): 107017. CrossRef - Insight into Antibiotic Synergy Combinations for Eliminating Colistin Heteroresistant Klebsiella pneumoniae
Sahaya Glingston Rajakani, Basil Britto Xavier, Adwoa Sey, El Bounja Mariem, Christine Lammens, Herman Goossens, Youri Glupczynski, Surbhi Malhotra-Kumar
Genes.2023; 14(7): 1426. CrossRef -
Mechanisms and Clinical Relevance of
Pseudomonas aeruginosa
Heteroresistance
Zhao Chen
Surgical Infections.2023; 24(1): 27. CrossRef - Heteroresistance Is Associated With in vitro Regrowth During Colistin Treatment in Carbapenem-Resistant Klebsiella pneumoniae
Yifan Wang, Xinqian Ma, Lili Zhao, Yukun He, Wenyi Yu, Shining Fu, Wentao Ni, Zhancheng Gao
Frontiers in Microbiology.2022;[Epub] CrossRef - Prevalence of Mutated Colistin-Resistant Klebsiella pneumoniae: A Systematic Review and Meta-Analysis
Nik Yusnoraini Yusof, Nur Iffah Izzati Norazzman, Siti Nur’ain Warddah Ab Hakim, Mawaddah Mohd Azlan, Amy Amilda Anthony, Fatin Hamimi Mustafa, Naveed Ahmed, Ali A. Rabaan, Souad A. Almuthree, Abdulsalam Alawfi, Amer Alshengeti, Sara Alwarthan, Mohammed G
Tropical Medicine and Infectious Disease.2022; 7(12): 414. CrossRef - Antibiotic Heteroresistance in Klebsiella pneumoniae
Karolina Stojowska-Swędrzyńska, Adrianna Łupkowska, Dorota Kuczyńska-Wiśnik, Ewa Laskowska
International Journal of Molecular Sciences.2021; 23(1): 449. CrossRef - Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directions
Kathleen Tompkins, David van Duin
European Journal of Clinical Microbiology & Infectious Diseases.2021; 40(10): 2053. CrossRef